Investors in Via Transportation (NYSE: VIA) have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit related to the company's September 2025 IPO. The complaint alleges that the registration statement and prospectus contained materially misleading statements and omitted required disclosures. At the time of the IPO, Via was allegedly adding customers faster than they generated revenue, causing a decline in ARR per customer, and faced regulatory challenges in Germany. Via's stock has declined approximately 70% from its offering price to $14.52.

Class action lawsuits have been filed against four publicly-traded companies alleging securities fraud. Erasca faces allegations regarding misleading preclinical data comparisons; Via Transportation failed to disclose declining ARR and regulatory issues; Embecta misrepresented guidance and segment weakness; and Zillow mischaracterized its Redfin agreement and downplayed antitrust risks. Investors have until mid-August 2026 to file lead plaintiff motions.

Kahn Swick & Foti, LLC announces a securities class action lawsuit against Via Transportation, Inc. for allegedly omitting material information in its September 2025 IPO prospectus. The complaint alleges the company failed to disclose obstacles including slower customer revenue generation and regulatory challenges in Germany. Via's stock has declined approximately 70% from its offering price to $14.52.

Rosen Law Firm announces securities class action lawsuits against Via Transportation, Inc., GPGI, Inc. (formerly CompoSecure), and ADMA Biologics, Inc. The firm is seeking lead plaintiffs with losses exceeding $100,000 before the August 10, 2026 deadline. Via's lawsuit alleges the IPO offering documents were false and misleading regarding declining revenue and growth obstacles, resulting in a 70% stock decline.

GeneDx Holdings Corp. (WGS) investors with substantial losses have until August 3, 2026 to seek appointment as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that GeneDx made false and misleading statements regarding the viability of its Fabric Genomics acquisition. GeneDx's stock dropped over 49% on May 4, 2026 after revealing a significant drop in adjusted gross margin from 74% to 69%, reduced earnings projections, and a $31.3 million impairment loss directly attributable to Fabric Genomics.

Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against Via Transportation, Inc. for alleged securities fraud related to its September 2025 IPO. The lawsuit claims the IPO offering documents were materially false and misleading, omitting that the company was adding customers faster than they generated revenue and facing regulatory headwinds in Germany. Via Transportation stock has declined approximately 70% below its $46 IPO price following successive negative earnings announcements in November 2025, February 2026, and May 2026.

ClaimsFiler reminds investors with losses exceeding $100,000 that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against Via Transportation. The lawsuit alleges that Via's IPO registration statement and prospectus contained materially misleading statements and omitted material information. The complaint claims that at the time of the IPO, Via was adding customers faster than they were generating revenue, resulting in declining ARR per customer, and faced regulatory obstacles in Germany. Via's stock has declined approximately 70% from its offering price to $14.52.

Grabar Law Office announced investigations into multiple publicly traded companies on behalf of shareholders, alleging breaches of fiduciary duties and securities law violations. The investigations cover Erasca (misleading statements about ERAS-0015 drug candidate and patent infringement), Insulet (defective manufacturing controls leading to product recalls), New Era Energy & Digital (overstated project progress and fraudulent oil-and-gas schemes), Power Solutions International (overstated sales demand and understated manufacturing costs), Hub Group, Planet Fitness, Primoris Services, EquipmentShare.com, GPGI, Photronics, and Via Transportation. Shareholders who meet specific holding criteria may seek damages and corporate governance reforms at no cost.

Kahn Swick & Foti, LLC announces a securities class action lawsuit against Via Transportation, Inc. for allegedly omitting material information in its September 2025 IPO prospectus. The complaint alleges the company failed to disclose obstacles including slower customer revenue generation and regulatory issues in Germany. Via's stock has declined approximately 70% from its offering price to $14.52.

Rosen Law Firm is notifying investors about securities class action lawsuits, with an August 10, 2026 deadline to serve as lead plaintiff. The main case involves Via Transportation, Inc., where the firm alleges the IPO offering documents were false and misleading regarding the company's declining revenue growth and inability to expand in Germany, resulting in a ~70% stock price decline.

Shareholder class action lawsuits have been filed against Embecta Corp. and Via Transportation Inc., with allegations of false statements and failure to disclose segment weakness and revenue guidance disruptions. Additionally, Holzer & Holzer, LLC announced an investigation into ADTRAN Holdings Inc. regarding potential federal securities law violations. Investors who suffered losses during the relevant periods are encouraged to contact the law firm.

Holzer & Holzer, LLC has filed shareholder class action lawsuits against Via Transportation and Embecta Corp., alleging false and misleading statements in their IPO registration statements and securities disclosures. The firm is also investigating ADTRAN Holdings for potential federal securities law violations. Investors who suffered losses are encouraged to contact the firm.